Navigation Links
The hepatitis healing power of blueberry leaves
Date:8/7/2009

A chemical found in blueberry leaves has shown a strong effect in blocking the replication of the Hepatitis C virus, opening up a new avenue for treating chronic HCV infections, which affect 200 million people worldwide and can eventually lead to cirrhosis and liver cancer.

Among the areas of especially high Hepatitis C incidence is the Miyazaki prefecture of southern Japan, a trend that led Hiroaki Kataoka and colleagues at the University of Miyazaki and elsewhere in Japan on a search for better treatment options. Currently, there is no vaccine for HCV, and though a combination drug regimen can clear HCV infection, this treatment is only about 60% effective on average and poses risks of severe side effects.

Kataoka and colleagues believed that since HCV is localized in the liver and can take 20 years or more to develop into disease, a dietary supplement might help slow or stop disease progression. So they screened nearly 300 different agricultural products for potential compounds that suppress HCV replication and uncovered a strong candidate in the leaves of rabbit-eye blueberry (native to the southeastern US).

They purified the compound and identified it as proanthocyandin (a polyphenol similar to the beneficial chemicals found in grapes and wine). While proanthocyandin can be harmful, Kataoka and colleagues noted its effective concentration against HCV was 100 times less than the toxic threshold, and similar chemicals are found in many edible plants, suggesting it should be safe as a dietary supplement. In the meantime, the researchers now hope to explore the detailed mechanisms of how this chemical stops HCV replication.


'/>"/>

Contact: Nick Zagorski
nzagorski@asbmb.org
301-634-7366
American Society for Biochemistry and Molecular Biology
Source:Eurekalert

Page: 1

Related biology news :

1. First human gets new antibody aimed at hepatitis C virus
2. Novel antibody prevents infection by hepatitis C virus
3. Biolex presents Locteron US Phase 2a hepatitis C data at EASL
4. When acute hepatitis develops into chronic hepatitis
5. Discovery could lead to a new animal model for hepatitis C
6. Leeds research points to new therapy for hepatitis C treatment
7. Nano vaccine for hepatitis B shows promise for third world
8. Hepatitis C virus may need enzymes help to cause liver disease
9. BARACLUDE data show low resistance over 5 years in nucleoside-naive hepatitis B patients
10. New hope for hepatitis C sufferers
11. Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
Breaking Biology News(10 mins):
(Date:7/13/2017)... ... July 13, 2017 , ... Trinity Sterile, Inc., a fast-growing ... has chosen The Copley Consulting Group to implement and deploy the Infor CloudSuite ... internal and backend operations to streamline efficiencies to meet the increasing demand for ...
(Date:7/12/2017)... City, Utah (PRWEB) , ... July 12, 2017 , ... ... developed and intends to manufacture and sell reagents used for diagnostic tests, announced today ... at $6.00 per share. Total gross proceeds from the offering will be $7,071,192. , ...
(Date:7/12/2017)... CA (PRWEB) , ... July 12, 2017 , ... Dr. ... is the most recent recipient of a Microbiome Impact Grant from uBiome, the leading ... role of the skin microbiome in the transmission of pathogens between elderly people in ...
(Date:7/12/2017)... (PRWEB) , ... July 12, 2017 , ... Exact Diagnostics ... Panels for In Vitro Diagnostic (IVD) use. Panels available include: Adenovirus, ... , The Exact Diagnostics Verification Panels may be used as calibrators to ...
Breaking Biology Technology: